.................
LaBranche & Co Inc. to Broadcast Review of First Quarter 2010 Earnings Live over the Internet
LaBranche & Co Inc. (NYSE: LAB) (the “Company”) announced today that it will release first quarter 2010 financial results before the open of the market on Tuesday, April 20, 2010. The Company will host a conference call which will be broadcast live over the Internet on Tuesday, April 20, 2010 at 9:00 a.m. Eastern Time. The broadcast will be hosted on the Company’s web site located at www.labranche.com.
Please allow extra time prior to the call to visit the site and download the streaming media software required to listen to the Internet broadcast. An online archive of the broadcast will be available within two hours of the live call.
The Company is the parent of LaBranche Structured Holdings, Inc., whose subsidiaries are market-makers in options, exchange-traded funds and futures on various exchanges domestically and internationally, and LaBranche Financial Services, LLC, which provides securities execution, fixed income and brokerage services to institutional investors.
Recent LAB News
- Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth • GlobeNewswire Inc. • 04/25/2024 12:01:00 PM
- Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024 • GlobeNewswire Inc. • 04/25/2024 12:00:00 PM
- Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research • GlobeNewswire Inc. • 04/03/2024 08:01:13 PM
- Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock • GlobeNewswire Inc. • 03/18/2024 12:12:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 12:20:18 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:05:55 PM
- Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/28/2024 09:01:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/26/2024 09:15:31 PM
- Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing • GlobeNewswire Inc. • 02/26/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 10:01:56 PM
- Standard BioTools to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/22/2024 09:05:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 08:32:04 PM
- Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 • GlobeNewswire Inc. • 02/14/2024 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/08/2024 05:15:32 AM
- Standard BioTools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized Medicine • GlobeNewswire Inc. • 02/07/2024 01:30:35 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/02/2024 09:49:35 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/19/2024 10:07:18 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/19/2024 10:05:28 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/19/2024 10:03:57 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/19/2024 09:48:03 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/19/2024 09:33:24 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/12/2024 07:04:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 01:51:32 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM